Uveal effusion syndrome secondary to belantamab mafodotin in a patient treated for refractory myeloma
2013 ◽
Vol 27
(4)
◽
pp. 294
◽
2006 ◽
Vol 20
(2)
◽
pp. 124
◽
2004 ◽
Vol 88
(1)
◽
pp. 153-154
◽
Keyword(s):